Australian Pharmaceutical Industries Ltd
ASX:API
Relative Value
There is not enough data to reliably calculate the relative value of API.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
API Competitors Multiples
Australian Pharmaceutical Industries Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
Australian Pharmaceutical Industries Ltd
ASX:API
|
753.8m AUD | 0.2 | 547.4 | 41.1 | 41.1 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.7B USD | 0.2 | 23.2 | 16.1 | 18.8 | ||
US |
Cencora Inc
NYSE:COR
|
44.7B USD | 0.2 | 24.1 | 16.7 | 16.7 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 0.1 | 37.8 | 8.5 | 11.4 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.7 | 21.2 | 11.2 | 15.1 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
59.3B CNY | 1.5 | 21.9 | 16 | 16 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
63.2B HKD | 0.1 | 6.6 | 1.6 | 1.9 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.4B EUR | 3.3 | 48 | 15.4 | 30.4 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.5B CNY | 0.2 | 13.7 | 8.1 | 8.1 |